MYC expression has been seen previously to regulate the immune TME in other malignancies, including hematologic malignancies, liver cancer, non-small cell lung cancer, and neuroblastoma, among others, through modulation of both immune effector cells and immune regulatory cytokines27–31. The gene discussed is MYC; the disease is non-small cell lung carcinoma.